At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...